Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 293, pseudogene (RN7SL293P) is a processed pseudogene that originates from the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP). Unlike the functional 7SL RNA genes (which play a role in protein targeting to the endoplasmic reticulum as part of the SRP complex), RN7SL pseudogenes are truncated and nonfunctional, typically formed by reverse transcription events from RNA back into the genome. They are dispersed throughout the genome, do not encode for proteins, and are not involved in direct cellular signaling or metabolic pathways. While some pseudogenes have been reported to affect gene regulation (for instance, as potential competing endogenous RNAs), there is no direct evidence for such a role with RN7SL293P[1][3][8]. Most of these 7SL pseudogenes, including RN7SL293P, are considered genomic fossils and are not expressed, nor do they have a known physiological or pathological function. References to similar loci and background context: - 7SL RNA is an essential component of the signal recognition particle but only a few loci in the human genome encode functional 7SL RNA, and the rest, such as RN7SL293P, are nonfunctional pseudogenes[1][3][5][7]. - The majority of these pseudogenes result from retrotransposition and are scattered throughout the genome, most with no detectable expression or function[1][3][4][8]. - Some pseudogenes (not specifically RN7SL293P) can modulate gene expression by acting as microRNA sponges or through other noncoding RNA-based mechanisms, but such functions are not established for this locus[4]. Summary statement: RN7SL293P is a noncoding RNA pseudogene derived from the 7SL RNA gene family; it does not have a therapeutic or disease target function, established biological activity, or relevance in drug interaction or biomarker applications. Its primary significance is as a genomic remnant of evolutionary retrotransposition events[1][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 293, pseudogene (RN7SL293P).